Logo image of ALHUN.PA

HUNYVERS SACA (ALHUN.PA) Stock Fundamental Analysis

EPA:ALHUN - FR0014007LQ2 - Common Stock

7.8 EUR
-0.14 (-1.76%)
Last: 9/11/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALHUN. ALHUN was compared to 47 industry peers in the Specialty Retail industry. ALHUN has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALHUN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ALHUN was profitable.
ALHUN had a negative operating cash flow in the past year.
Each year in the past 5 years ALHUN has been profitable.
Of the past 5 years ALHUN 4 years had a positive operating cash flow.
ALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

ALHUN has a Return On Assets of 1.91%. This is comparable to the rest of the industry: ALHUN outperforms 59.57% of its industry peers.
The Return On Equity of ALHUN (6.43%) is comparable to the rest of the industry.
ALHUN has a better Return On Invested Capital (5.48%) than 65.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALHUN is in line with the industry average of 8.09%.
The last Return On Invested Capital (5.48%) for ALHUN is well below the 3 year average (9.61%), which needs to be investigated, but indicates that ALHUN had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.91%
ROE 6.43%
ROIC 5.48%
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ALHUN.PA Yearly ROA, ROE, ROICALHUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

Looking at the Profit Margin, with a value of 1.41%, ALHUN is in the better half of the industry, outperforming 61.70% of the companies in the same industry.
ALHUN's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 2.48%, ALHUN perfoms like the industry average, outperforming 53.19% of the companies in the same industry.
ALHUN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 19.89%, ALHUN is not doing good in the industry: 76.60% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ALHUN has grown nicely.
Industry RankSector Rank
OM 2.48%
PM (TTM) 1.41%
GM 19.89%
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
ALHUN.PA Yearly Profit, Operating, Gross MarginsALHUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

ALHUN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ALHUN has about the same amout of shares outstanding than it did 1 year ago.
ALHUN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALHUN has a worse debt to assets ratio.
ALHUN.PA Yearly Shares OutstandingALHUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALHUN.PA Yearly Total Debt VS Total AssetsALHUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.32 indicates that ALHUN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.32, ALHUN perfoms like the industry average, outperforming 57.45% of the companies in the same industry.
ALHUN has a Debt/Equity ratio of 0.71. This is a neutral value indicating ALHUN is somewhat dependend on debt financing.
ALHUN has a Debt to Equity ratio (0.71) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z 2.32
ROIC/WACC0.87
WACC6.27%
ALHUN.PA Yearly LT Debt VS Equity VS FCFALHUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

ALHUN has a Current Ratio of 1.66. This is a normal value and indicates that ALHUN is financially healthy and should not expect problems in meeting its short term obligations.
ALHUN's Current ratio of 1.66 is fine compared to the rest of the industry. ALHUN outperforms 76.60% of its industry peers.
A Quick Ratio of 0.46 indicates that ALHUN may have some problems paying its short term obligations.
ALHUN has a Quick ratio of 0.46. This is comparable to the rest of the industry: ALHUN outperforms 40.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 0.46
ALHUN.PA Yearly Current Assets VS Current LiabilitesALHUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. Growth

3.1 Past

ALHUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.70%.
ALHUN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
Looking at the last year, ALHUN shows a quite strong growth in Revenue. The Revenue has grown by 15.96% in the last year.
Measured over the past years, ALHUN shows a very strong growth in Revenue. The Revenue has been growing by 26.45% on average per year.
EPS 1Y (TTM)-52.7%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%-1.2%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%17.55%

3.2 Future

The Earnings Per Share is expected to grow by 25.39% on average over the next years. This is a very strong growth
ALHUN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.55% yearly.
EPS Next Y-19.73%
EPS Next 2Y15.18%
EPS Next 3Y17.59%
EPS Next 5Y25.39%
Revenue Next Year-0.83%
Revenue Next 2Y3.79%
Revenue Next 3Y4.06%
Revenue Next 5Y4.55%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALHUN.PA Yearly Revenue VS EstimatesALHUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
ALHUN.PA Yearly EPS VS EstimatesALHUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.25, the valuation of ALHUN can be described as correct.
ALHUN's Price/Earnings ratio is rather cheap when compared to the industry. ALHUN is cheaper than 82.98% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALHUN to the average of the S&P500 Index (27.44), we can say ALHUN is valued slightly cheaper.
A Price/Forward Earnings ratio of 12.84 indicates a correct valuation of ALHUN.
Based on the Price/Forward Earnings ratio, ALHUN is valued a bit cheaper than the industry average as 70.21% of the companies are valued more expensively.
ALHUN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.25
Fwd PE 12.84
ALHUN.PA Price Earnings VS Forward Price EarningsALHUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ALHUN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.93
ALHUN.PA Per share dataALHUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

ALHUN's earnings are expected to grow with 17.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.18%
EPS Next 3Y17.59%

0

5. Dividend

5.1 Amount

ALHUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HUNYVERS SACA

EPA:ALHUN (9/11/2025, 7:00:00 PM)

7.8

-0.14 (-1.76%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.77%
Inst Owner ChangeN/A
Ins Owners2.63%
Ins Owner ChangeN/A
Market Cap30.19M
Analysts88
Price Target10.56 (35.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-26.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-26.25%
EPS NY rev (3m)-26.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.2%
Valuation
Industry RankSector Rank
PE 16.25
Fwd PE 12.84
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 1.89
EV/EBITDA 11.93
EPS(TTM)0.48
EY6.15%
EPS(NY)0.61
Fwd EY7.79%
FCF(TTM)-1.34
FCFYN/A
OCF(TTM)-1.13
OCFYN/A
SpS33.68
BVpS7.38
TBVpS4.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.91%
ROE 6.43%
ROCE 6.65%
ROIC 5.48%
ROICexc 6.59%
ROICexgc 9.48%
OM 2.48%
PM (TTM) 1.41%
GM 19.89%
FCFM N/A
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ROICexc(3y)11.28%
ROICexc(5y)11.76%
ROICexgc(3y)15.77%
ROICexgc(5y)16.95%
ROCE(3y)12.12%
ROCE(5y)10.83%
ROICexcg growth 3Y-40.67%
ROICexcg growth 5YN/A
ROICexc growth 3Y-38.4%
ROICexc growth 5YN/A
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
F-Score4
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 5.16
Cap/Depr 114.18%
Cap/Sales 0.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 0.46
Altman-Z 2.32
F-Score4
WACC6.27%
ROIC/WACC0.87
Cap/Depr(3y)138.87%
Cap/Depr(5y)108.48%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.7%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%-1.2%
EPS Next Y-19.73%
EPS Next 2Y15.18%
EPS Next 3Y17.59%
EPS Next 5Y25.39%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%17.55%
Revenue Next Year-0.83%
Revenue Next 2Y3.79%
Revenue Next 3Y4.06%
Revenue Next 5Y4.55%
EBIT growth 1Y-40.5%
EBIT growth 3Y5.15%
EBIT growth 5YN/A
EBIT Next Year42.55%
EBIT Next 3Y22.31%
EBIT Next 5Y24.35%
FCF growth 1Y-2895.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-494.17%
OCF growth 3YN/A
OCF growth 5YN/A